Impact of COVID-19 on reperfusion strategies for acute coronary syndromes.
Impact of COVID-19 on reperfusion strategies for acute coronary syndromes.
Arch Cardiol Mex. 2020;90(Supl):62-66
Authors: Torres-Escobar G, González-Pacheco H, Cruz JLB, Arias-Mendoza A, Araiza-Garaygordobil D
Abstract
Reperfusion therapy is a measure of care in patients with ST-elevation myocardial infarction (STEMI), which should be performed once we have the diagnosis. Percutaneous coronary intervention is considered the gold standard, however in patients with SARS-CoV-2 infection, the reperfusion strategy is more focused on fibrinolytic therapy due to the shorter time required to perform and less exposure. This pandemic represents a contact problem in health personnel, since cases are increasing worldwide, so it is important to know the measures that must be followed to avoid coronavirus disease (COVID-19).
PMID: 32523136 [PubMed - in process]
Source: Archivos de Cardiologia de Mexico - Category: Cardiology Authors: Torres-Escobar G, González-Pacheco H, Cruz JLB, Arias-Mendoza A, Araiza-Garaygordobil D Tags: Arch Cardiol Mex Source Type: research
More News: Angioplasty | Cardiology | Coronary Angioplasty | Coronavirus | COVID-19 | Heart | Heart Attack | Men | Mexico Health | Pandemics | Percutaneous Coronary Intervention | SARS